"Heart Function Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Examinations used to diagnose and treat heart conditions.
| Descriptor ID |
D006334
|
| MeSH Number(s) |
E01.370.370.380
|
| Concept/Terms |
Heart Function Tests- Heart Function Tests
- Function Test, Heart
- Function Tests, Heart
- Heart Function Test
- Test, Heart Function
- Tests, Heart Function
- Cardiac Function Tests
- Cardiac Function Test
- Function Test, Cardiac
- Function Tests, Cardiac
- Test, Cardiac Function
- Tests, Cardiac Function
|
Below are MeSH descriptors whose meaning is more general than "Heart Function Tests".
Below are MeSH descriptors whose meaning is more specific than "Heart Function Tests".
This graph shows the total number of publications written about "Heart Function Tests" by people in this website by year, and whether "Heart Function Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2005 | 1 | 2 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 2 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 0 | 2 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 2 | 0 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heart Function Tests" by people in Profiles.
-
Resumption of Cardiac Activity after Withdrawal of Life-Sustaining Measures. N Engl J Med. 2021 01 28; 384(4):345-352.
-
A steroid receptor coactivator stimulator (MCB-613) attenuates adverse remodeling after myocardial infarction. Proc Natl Acad Sci U S A. 2020 12 08; 117(49):31353-31364.
-
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. Circulation. 2020 07 07; 142(1):e7-e22.
-
Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019 Jun; 69(6S):3S-125S.e40.
-
Trends in Use of Biomarker Protocols for the Evaluation of Possible Myocardial Infarction. J Am Heart Assoc. 2017 Sep 22; 6(9).
-
Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity. Oncotarget. 2017 Jan 17; 8(3):4837-4848.
-
Cardiomyocyte-specific conditional knockout of the histone chaperone HIRA in mice results in hypertrophy, sarcolemmal damage and focal replacement fibrosis. Dis Model Mech. 2016 Mar; 9(3):335-45.
-
Safety and physiological effects of two different doses of elosulfase alfa in patients with morquio a syndrome: A randomized, double-blind, pilot study. Am J Med Genet A. 2015 Oct; 167A(10):2272-81.
-
Outcomes of anomalous left coronary artery from pulmonary artery repair: beyond normal function. Ann Thorac Surg. 2015 Apr; 99(4):1342-7.
-
2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):e5-23.